ArticleEuropean journal of medical research2025
CACNB4 attenuates cardiac dysfunction by regulating calcium and ATP levels via interaction with RyR2.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A recombinant humanized type III collagen coating with anti-inflammatory and endothelialization-promoting effects for left atrial appendage closure devices.Regenerative biomaterials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
CACNB4 is suspected to be involved in cardiac contraction, its specific role and the underlying mechanisms are not elucidated. We analyzed gene expression profiles of peripheral blood mononuclear cells (PBMCs) from heart failure patients using the GSE235757 data set from the NCBI GEO database. KEGG enrichment analysis was performed to identify pathways associated with differentially expressed genes. Analysis of the GSE235757 data set revealed a significant downregulation of CACNB4 expression in PBMCs of heart failure patients, particularly in the "Cardiac muscle contraction" pathway. Western blot analysis confirmed a reduction in CACNB4 expression in hypoxic myocardial cells and heart tissue from heart failure mice. Overexpression of CACNB4 improved cardiac function, reduced infarct size, alleviated myocardial damage, via enhancing ATP and Ca
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.